We are live on ! Find out more
VTAK icon

Catheter Precision

6 hedge funds and large institutions have $2.77M invested in Catheter Precision in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

20% more funds holding

Funds holding: 56 (+1)

0% more ownership

Funds ownership: 0%0% (+0%)

15% less capital invested

Capital invested by funds: $3.27M → $2.77M (-$506K)

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.12%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
2
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

VTAK Hedge Fund Activity: Q4 2019 in Review

6 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q4 2019, worth a combined $2.77M — down 15% from $3.27M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new VTAK positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Bourne Lent Asset Management, opening a new position worth an estimated $305K. The largest seller was BAMCO Inc, exiting entirely with an estimated $713K sold.

  • 6 institutional investors held Catheter Precision (VTAK) as of Q4 2019, up from 5 in Q3 2019.
  • Funds reported $2.77M of Catheter Precision stock for Q4 2019, down 15% quarter-over-quarter.
  • 2 funds opened new Catheter Precision positions in Q4 2019 and 1 closed out, a net change of +1 holder.
  • The largest Catheter Precision buyer in Q4 2019 was Bourne Lent Asset Management, an estimated $305K added.
  • The largest Catheter Precision seller in Q4 2019 was BAMCO Inc, an estimated $713K sold.

Based on aggregated 13F filings for Q4 2019.